["[{\"Possible Vaccine Adverse Events\":\"1p36 deletion syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"2-Hydroxyglutaric aciduria\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"5'nucleotidase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acoustic neuritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acquired C1 inhibitor deficiency\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acquired epidermolysis bullosa\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acquired epileptic aphasia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute cutaneous lupus erythematosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute disseminated encephalomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute encephalitis with refractory, repetitive partial seizures\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute febrile neutrophilic dermatosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute flaccid myelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute haemorrhagic leukoencephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute haemorrhagic oedema of infancy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute kidney injury\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute macular outer retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute motor axonal neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute motor-sensory axonal neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute myocardial infarction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute respiratory distress syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Acute respiratory failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Addison's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Administration site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Administration site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Adrenal thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Adverse event following immunisation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ageusia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Agranulocytosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Air embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alanine aminotransferase abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alanine aminotransferase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alcoholic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Allergic bronchopulmonary mycosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Allergic oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alloimmune hepatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alopecia areata\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alpers disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Alveolar proteinosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ammonia abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ammonia increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Amniotic cavity infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Amygdalohippocampectomy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Amyloid arthropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Amyloidosis senile\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anaphylactic reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anaphylactic shock\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anaphylactic transfusion reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anaphylactoid reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anaphylactoid shock\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anaphylactoid syndrome of pregnancy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Angioedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Angiopathic neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ankylosing spondylitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anosmia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antiacetylcholine receptor antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-actin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-aquaporin-4 antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-basal ganglia antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-cyclic citrullinated peptide antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-epithelial antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-erythrocyte antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-exosome complex antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-GAD antibody negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-GAD antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-ganglioside antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antigliadin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-glomerular basement membrane antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-glomerular basement membrane disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-glycyl-tRNA synthetase antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-HLA antibody test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-IA2 antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-insulin antibody increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-insulin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-insulin receptor antibody increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-insulin receptor antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-interferon antibody negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-interferon antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-islet cell antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antimitochondrial antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-muscle specific kinase antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-myelin-associated glycoprotein antibodies positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-myelin-associated glycoprotein associated polyneuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antimyocardial antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-neuronal antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antineutrophil cytoplasmic antibody increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antineutrophil cytoplasmic antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-neutrophil cytoplasmic antibody positive vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-NMDA antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antinuclear antibody increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antinuclear antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antiphospholipid antibodies positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antiphospholipid syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-platelet antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-prothrombin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antiribosomal P antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-RNA polymerase III antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-saccharomyces cerevisiae antibody test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-sperm antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-SRP antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antisynthetase syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-thyroid antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-transglutaminase antibody increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-VGCC antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-VGKC antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-vimentin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antiviral prophylaxis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Antiviral treatment\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Anti-zinc transporter 8 antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aortic embolus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aortic thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aortitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aplasia pure red cell\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aplastic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Application site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Application site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arrhythmia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arterial bypass occlusion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arterial bypass thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arterial thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arteriovenous fistula thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arteriovenous graft site stenosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arteriovenous graft thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arteritis coronary\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arthralgia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Arthritis enteropathic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ascites\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aseptic cavernous sinus thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aspartate aminotransferase abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aspartate aminotransferase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aspartate-glutamate-transporter deficiency\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"AST to platelet ratio index increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"AST/ALT ratio abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Asthma\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Asymptomatic COVID-19\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ataxia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Atheroembolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Atonic seizures\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Atrial thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Atrophic thyroiditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Atypical benign partial epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Atypical pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Aura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoantibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune aplastic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune blistering disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune cholangitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune colitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune demyelinating disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune dermatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune encephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune endocrine disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune enteropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune eye disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune haemolytic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune heparin-induced thrombocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune hepatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune hyperlipidaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune hypothyroidism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune inner ear disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune lung disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune lymphoproliferative syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune myocarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune myositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune nephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune pancreatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune pancytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune pericarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune thyroid disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune thyroiditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune uveitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoinflammation with infantile enterocolitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autoinflammatory disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Automatism epileptic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autonomic nervous system imbalance\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Autonomic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Axial spondyloarthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Axillary vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Axonal and demyelinating polyneuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Axonal neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bacterascites\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Baltic myoclonic epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Band sensation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Basedow's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Basilar artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Basophilopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"B-cell aplasia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Behcet's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Benign ethnic neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Benign familial neonatal convulsions\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Benign familial pemphigus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Benign rolandic epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Beta-2 glycoprotein antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bickerstaff's encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bile output abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bile output decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Biliary ascites\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bilirubin conjugated abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bilirubin conjugated increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bilirubin urine present\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Biopsy liver abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Biotinidase deficiency\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Birdshot chorioretinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood alkaline phosphatase abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood alkaline phosphatase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood bilirubin abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood bilirubin increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood bilirubin unconjugated increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood cholinesterase abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood cholinesterase decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood pressure decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood pressure diastolic decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blood pressure systolic decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Blue toe syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Brachiocephalic vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Brain stem embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Brain stem thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bromosulphthalein test abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bronchial oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bronchitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bronchitis mycoplasmal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bronchitis viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bronchopulmonary aspergillosis allergic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bronchospasm\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Budd-Chiari syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Bulbar palsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Butterfly rash\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"C1q nephropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Caesarean section\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Calcium embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Capillaritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Caplan's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiac amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiac arrest\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiac failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiac failure acute\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiac sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiac ventricular thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiogenic shock\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiolipin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiopulmonary failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardio-respiratory arrest\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardio-respiratory distress\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cardiovascular insufficiency\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Carotid arterial embolus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Carotid artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cataplexy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Catheter site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Catheter site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cavernous sinus thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"CDKL5 deficiency disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"CEC syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cement embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Central nervous system lupus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Central nervous system vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebellar artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebellar embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral amyloid angiopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral arteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral gas embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral microembolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral septic infarct\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral venous sinus thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebral venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebrospinal thrombotic tamponade\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cerebrovascular accident\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Change in seizure presentation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chest discomfort\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Child-Pugh-Turcotte score abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Child-Pugh-Turcotte score increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chillblains\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Choking\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Choking sensation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cholangitis sclerosing\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic autoimmune glomerulonephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic cutaneous lupus erythematosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic fatigue syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic gastritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic inflammatory demyelinating polyradiculoneuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic recurrent multifocal osteomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic respiratory failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Chronic spontaneous urticaria\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Circulatory collapse\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Circumoral oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Circumoral swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Clinically isolated syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Clonic convulsion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coeliac disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cogan's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cold agglutinins positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cold type haemolytic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Colitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Colitis erosive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Colitis herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Colitis microscopic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Colitis ulcerative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Collagen disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Collagen-vascular disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Complement factor abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Complement factor C1 decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Complement factor C2 decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Complement factor C3 decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Complement factor C4 decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Complement factor decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Computerised tomogram liver abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Concentric sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Congenital anomaly\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Congenital bilateral perisylvian syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Congenital herpes simplex infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Congenital myasthenic syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Congenital varicella infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Congestive hepatopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Convulsion in childhood\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Convulsions local\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Convulsive threshold lowered\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coombs positive haemolytic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronary artery disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronary artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronary artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronary bypass thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronavirus infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronavirus test\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronavirus test negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Coronavirus test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Corpus callosotomy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cough\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cough variant asthma\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"COVID-19\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"COVID-19 immunisation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"COVID-19 pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"COVID-19 prophylaxis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"COVID-19 treatment\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cranial nerve disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cranial nerve palsies multiple\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cranial nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"CREST syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Crohn's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cryofibrinogenaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cryoglobulinaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"CSF oligoclonal band present\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"CSWS syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cutaneous amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cutaneous lupus erythematosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cutaneous sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cutaneous vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cyanosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cyclic neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cystitis interstitial\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cytokine release syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Cytokine storm\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"De novo purine synthesis inhibitors associated acute inflammatory syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Death neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Deep vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Deep vein thrombosis postoperative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Deficiency of bile secretion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Deja vu\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Demyelinating polyneuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Demyelination\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dermatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dermatitis bullous\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dermatitis herpetiformis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dermatomyositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Device embolisation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Device related thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Diabetes mellitus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Diabetic ketoacidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Diabetic mastopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dialysis amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dialysis membrane reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Diastolic hypotension\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Diffuse vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Digital pitting scar\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Disseminated intravascular coagulation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Disseminated intravascular coagulation in newborn\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Disseminated neonatal herpes simplex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Disseminated varicella\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Disseminated varicella zoster vaccine virus infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Disseminated varicella zoster virus infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"DNA antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Double cortex syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Double stranded DNA antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dreamy state\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dressler's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Drop attacks\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Drug withdrawal convulsions\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Dyspnoea\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Early infantile epileptic encephalopathy with burst-suppression\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eclampsia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eczema herpeticum\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolia cutis medicamentosa\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolic cerebellar infarction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolic cerebral infarction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolic pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolic stroke\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolism arterial\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Embolism venous\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis allergic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis autoimmune\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis brain stem\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis haemorrhagic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis periaxialis diffusa\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis post immunisation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Encephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Endocrine disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Endocrine ophthalmopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Endotracheal intubation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Enteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Enteritis leukopenic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Enterobacter pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Enterocolitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Enteropathic spondylitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eosinopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eosinophilic fasciitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eosinophilic granulomatosis with polyangiitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eosinophilic oesophagitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Epidermolysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Epilepsy surgery\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Epilepsy with myoclonic-atonic seizures\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Epileptic aura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Epileptic psychosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Erythema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Erythema induratum\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Erythema multiforme\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Erythema nodosum\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Evans syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Exanthema subitum\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Expanded disability status scale score decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Expanded disability status scale score increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Exposure to communicable disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Exposure to SARS-CoV-2\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eye oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eye pruritus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eye swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Eyelid oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Face oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Facial paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Facial paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Faciobrachial dystonic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Fat embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Febrile convulsion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Febrile infection-related epilepsy syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Febrile neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Felty's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Femoral artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Fibrillary glomerulonephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Fibromyalgia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Flushing\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Foaming at mouth\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Focal cortical resection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Focal dyscognitive seizures\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Foetal distress syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Foetal placental thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Foetor hepaticus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Foreign body embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Frontal lobe epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Fulminant type 1 diabetes mellitus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Galactose elimination capacity test abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Galactose elimination capacity test decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Gamma-glutamyltransferase abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Gamma-glutamyltransferase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Gastritis herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Gastrointestinal amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Gelastic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Generalised onset non-motor seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Generalised tonic-clonic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Genital herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Genital herpes simplex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Genital herpes zoster\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Giant cell arteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glomerulonephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glomerulonephritis membranoproliferative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glomerulonephritis membranous\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glomerulonephritis rapidly progressive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glossopharyngeal nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glucose transporter type 1 deficiency syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glutamate dehydrogenase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Glycocholic acid increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"GM2 gangliosidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Goodpasture's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Graft thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Granulocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Granulocytopenia neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Granulomatosis with polyangiitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Granulomatous dermatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Grey matter heterotopia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Guanase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Guillain-Barre syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemolytic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemophagocytic lymphohistiocytosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemorrhage\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemorrhagic ascites\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemorrhagic disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemorrhagic pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemorrhagic varicella syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Haemorrhagic vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hantavirus pulmonary infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hashimoto's encephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hashitoxicosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hemimegalencephaly\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Henoch-Schonlein purpura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Henoch-Schonlein purpura nephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepaplastin abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepaplastin decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Heparin-induced thrombocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic artery flow decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic enzyme abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic enzyme decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic enzyme increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic fibrosis marker abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic fibrosis marker increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic function abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic hydrothorax\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic hypertrophy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic hypoperfusion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic lymphocytic infiltration\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic mass\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic pain\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic sequestration\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic vascular resistance increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic vascular thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic vein embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic venous pressure gradient abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatic venous pressure gradient increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatobiliary scan abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatomegaly\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hepatosplenomegaly\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hereditary angioedema with C1 esterase inhibitor deficiency\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes dermatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes gestationis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes oesophagitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes ophthalmic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes pharyngitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes sepsis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex cervicitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex colitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex gastritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex hepatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex meningitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex meningoencephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex meningomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex necrotising retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex oesophagitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex otitis externa\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex pharyngitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex reactivation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex sepsis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex viraemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex virus conjunctivitis neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes simplex visceral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes virus infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster cutaneous disseminated\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster infection neurological\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster meningitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster meningoencephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster meningomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster meningoradiculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster necrotising retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster oticus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster pharyngitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpes zoster reactivation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Herpetic radiculopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Histone antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hoigne's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Human herpesvirus 6 encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Human herpesvirus 6 infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Human herpesvirus 6 infection reactivation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Human herpesvirus 7 infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Human herpesvirus 8 infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hyperammonaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hyperbilirubinaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypercholia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypergammaglobulinaemia benign monoclonal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hyperglycaemic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypersensitivity\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypersensitivity vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hyperthyroidism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypertransaminasaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hyperventilation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypoalbuminaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypocalcaemic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypogammaglobulinaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypoglossal nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypoglossal nerve paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypoglycaemic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hyponatraemic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypotension\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypotensive crisis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypothenar hammer syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypothyroidism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Hypoxia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Idiopathic CD4 lymphocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Idiopathic generalised epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Idiopathic interstitial pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Idiopathic neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Idiopathic pulmonary fibrosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IgA nephropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IgM nephropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IIIrd nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IIIrd nerve paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Iliac artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune thrombocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated adverse reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated cholangitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated cholestasis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated cytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated encephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated endocrinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated enterocolitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated gastritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated hepatic disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated hepatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated hyperthyroidism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated hypothyroidism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated myocarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated myositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated nephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated pancreatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated pneumonitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated renal disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated thyroiditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immune-mediated uveitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immunoglobulin G4 related disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Immunoglobulins abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Implant site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Inclusion body myositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Infantile genetic agranulocytosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Infantile spasms\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Infected vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Infective thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Inflammation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Inflammatory bowel disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Infusion site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Infusion site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Injection site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Injection site urticaria\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Injection site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Instillation site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Insulin autoimmune syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Interstitial granulomatous dermatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Interstitial lung disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Intracardiac mass\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Intracardiac thrombus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Intracranial pressure increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Intrapericardial thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Intrinsic factor antibody abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Intrinsic factor antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IPEX syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Irregular breathing\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IRVAN syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IVth nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"IVth nerve paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"JC polyomavirus test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"JC virus CSF test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Jeavons syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Jugular vein embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Jugular vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Juvenile idiopathic arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Juvenile myoclonic epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Juvenile polymyositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Juvenile psoriatic arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Juvenile spondyloarthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Kaposi sarcoma inflammatory cytokine syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Kawasaki's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Kayser-Fleischer ring\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Keratoderma blenorrhagica\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ketosis-prone diabetes mellitus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Kounis syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lafora's myoclonic epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lambl's excrescences\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Laryngeal dyspnoea\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Laryngeal oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Laryngeal rheumatoid arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Laryngospasm\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Laryngotracheal oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Latent autoimmune diabetes in adults\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"LE cells present\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lemierre syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lennox-Gastaut syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Leucine aminopeptidase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Leukoencephalomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Leukoencephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Leukopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Leukopenia neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lewis-Sumner syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lhermitte's sign\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lichen planopilaris\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lichen planus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lichen sclerosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Limbic encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Linear IgA disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lip oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lip swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver function test abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver function test decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver function test increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver induration\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver injury\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver iron concentration abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver iron concentration increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver opacity\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver palpable\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver scan abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Liver tenderness\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Low birth weight baby\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lower respiratory tract herpes infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lower respiratory tract infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lower respiratory tract infection viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lung abscess\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupoid hepatic cirrhosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus cystitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus endocarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus enteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus hepatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus myocarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus myositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus nephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus pancreatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus pleurisy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus pneumonitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lupus-like syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lymphocytic hypophysitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lymphocytopenia neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Lymphopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"MAGIC syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Magnetic resonance imaging liver abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Magnetic resonance proton density fat fraction measurement\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mahler sign\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Manufacturing laboratory analytical testing issue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Manufacturing materials issue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Manufacturing production issue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Marburg's variant multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Marchiafava-Bignami disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Marine Lenhart syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mastocytic enterocolitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Maternal exposure during pregnancy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Medical device site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Medical device site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"MELAS syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Meningitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Meningitis aseptic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Meningitis herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Meningoencephalitis herpes simplex neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Meningoencephalitis herpetic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Meningomyelitis herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"MERS-CoV test\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"MERS-CoV test negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"MERS-CoV test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mesangioproliferative glomerulonephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mesenteric artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mesenteric artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mesenteric vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Metapneumovirus infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Metastatic cutaneous Crohn's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Metastatic pulmonary embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Microangiopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Microembolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Microscopic polyangiitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Middle East respiratory syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Migraine-triggered seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Miliary pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Miller Fisher syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mitochondrial aspartate aminotransferase increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mixed connective tissue disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Model for end stage liver disease score abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Model for end stage liver disease score increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Molar ratio of total branched-chain amino acid to tyrosine\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Molybdenum cofactor deficiency\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Monocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mononeuritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mononeuropathy multiplex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Morphoea\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Morvan syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Mouth swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Moyamoya disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multifocal motor neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multiple organ dysfunction syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multiple sclerosis relapse\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multiple sclerosis relapse prophylaxis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multiple subpial transection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Multisystem inflammatory syndrome in children\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Muscular sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myasthenia gravis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myasthenia gravis crisis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myasthenia gravis neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myasthenic syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myelitis transverse\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myocardial infarction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myocarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myocarditis post infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myoclonic epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myoclonic epilepsy and ragged-red fibres\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myokymia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Myositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Narcolepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Nasal herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Nasal obstruction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Necrotising herpetic retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neonatal Crohn's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neonatal epileptic seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neonatal lupus erythematosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neonatal mucocutaneous herpes simplex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neonatal pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neonatal seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Nephritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Nephrogenic systemic fibrosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuralgic amyotrophy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuritis cranial\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuromyelitis optica pseudo relapse\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuromyelitis optica spectrum disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuromyotonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuronal neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuropathy peripheral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuropathy, ataxia, retinitis pigmentosa syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neuropsychiatric lupus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neurosarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neutropenia neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neutropenic colitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neutropenic infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Neutropenic sepsis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Nodular rash\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Nodular vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Noninfectious myelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Noninfective encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Noninfective encephalomyelitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Noninfective oophoritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Obstetrical pulmonary embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Occupational exposure to communicable disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Occupational exposure to SARS-CoV-2\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ocular hyperaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ocular myasthenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ocular pemphigoid\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ocular sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ocular vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oculofacial paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oedema blister\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oedema due to hepatic disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oedema mouth\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oesophageal achalasia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ophthalmic artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ophthalmic herpes simplex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ophthalmic herpes zoster\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ophthalmic vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Optic neuritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Optic neuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Optic perineuritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oral herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oral lichen planus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oropharyngeal oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oropharyngeal spasm\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Oropharyngeal swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Osmotic demyelination syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ovarian vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Overlap syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paget-Schroetter syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Palindromic rheumatism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Palisaded neutrophilic granulomatous dermatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Palmoplantar keratoderma\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Palpable purpura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pancreatitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Panencephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Papillophlebitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paracancerous pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paradoxical embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Parainfluenzae viral laryngotracheobronchitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paraneoplastic dermatomyositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paraneoplastic pemphigus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paraneoplastic thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paresis cranial nerve\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Parietal cell antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Paroxysmal nocturnal haemoglobinuria\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Partial seizures\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Partial seizures with secondary generalisation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Patient isolation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pelvic venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pemphigoid\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pemphigus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Penile vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pericarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pericarditis lupus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Perihepatic discomfort\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Periorbital oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Periorbital swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peripheral artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peripheral embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peripheral ischaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peripheral vein thrombus extension\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Periportal oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peritoneal fluid protein abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peritoneal fluid protein decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peritoneal fluid protein increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Peritonitis lupus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pernicious anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Petit mal epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pharyngeal oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pharyngeal swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pityriasis lichenoides et varioliformis acuta\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Placenta praevia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pleuroparenchymal fibroelastosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumobilia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia adenoviral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia cytomegaloviral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia herpes viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia influenzal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia measles\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia mycoplasmal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia necrotising\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia parainfluenzae viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia respiratory syncytial viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pneumonia viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"POEMS syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyarteritis nodosa\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyarthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polychondritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyglandular autoimmune syndrome type I\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyglandular autoimmune syndrome type II\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyglandular autoimmune syndrome type III\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyglandular disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polymicrogyria\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polymyalgia rheumatica\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polymyositis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyneuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Polyneuropathy idiopathic progressive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Portal pyaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Portal vein embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Portal vein flow decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Portal vein pressure increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Portal vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Portosplenomesenteric venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post procedural hypotension\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post procedural pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post procedural pulmonary embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post stroke epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post stroke seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post thrombotic retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post thrombotic syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post viral fatigue syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postictal headache\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postictal paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postictal psychosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postictal state\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postoperative respiratory distress\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postoperative respiratory failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postoperative thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postpartum thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postpartum venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postpericardiotomy syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Post-traumatic epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Postural orthostatic tachycardia syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Precerebral artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pre-eclampsia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Preictal state\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Premature labour\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Premature menopause\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Primary amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Primary biliary cholangitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Primary progressive multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Procedural shock\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Proctitis herpes\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Proctitis ulcerative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Product availability issue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Product distribution issue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Product supply issue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Progressive facial hemiatrophy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Progressive multifocal leukoencephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Progressive multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Progressive relapsing multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Prosthetic cardiac valve thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pruritus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pruritus allergic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pseudovasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Psoriasis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Psoriatic arthropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary fibrosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary haemorrhage\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary microemboli\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary oil microembolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary renal syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary sepsis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary tumour thrombotic microangiopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary veno-occlusive disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pulmonary venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pyoderma gangrenosum\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pyostomatitis vegetans\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Pyrexia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Quarantine\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Radiation leukopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Radiculitis brachial\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Radiologically isolated syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rash\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rash erythematous\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rash pruritic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rasmussen encephalitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Raynaud's phenomenon\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Reactive capillary endothelial proliferation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Relapsing multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Relapsing-remitting multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal arteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal vascular thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal vein embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Renal vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory arrest\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory distress\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory failure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory syncytial virus bronchiolitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Respiratory syncytial virus bronchitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal artery occlusion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal vascular thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal vein occlusion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinal vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinol binding protein decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retinopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retrograde portal vein flow\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Retroperitoneal fibrosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Reversible airways obstruction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Reynold's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatic brain disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatic disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid factor increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid factor positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid factor quantitative increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid lung\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid neutrophilic dermatosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid nodule\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid nodule removal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid scleritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Rheumatoid vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Saccadic eye movement\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SAPHO syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sarcoidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-1 test\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-1 test negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-1 test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 antibody test\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 antibody test negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 antibody test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 carrier\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 sepsis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 test\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 test false negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 test false positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 test negative\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 test positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SARS-CoV-2 viraemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Satoyoshi syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Schizencephaly\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Scleritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sclerodactylia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Scleroderma\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Scleroderma associated digital ulcer\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Scleroderma renal crisis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Scleroderma-like reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Secondary amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Secondary cerebellar degeneration\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Secondary progressive multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Segmented hyalinising vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Seizure\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Seizure anoxic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Seizure cluster\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Seizure like phenomena\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Seizure prophylaxis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sensation of foreign body\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Septic embolus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Septic pulmonary embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Severe acute respiratory syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Severe myoclonic epilepsy of infancy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Shock\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Shock symptom\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Shrinking lung syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Shunt thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Silent thyroiditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Simple partial seizures\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sjogren's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Skin swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"SLE arthritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Smooth muscle antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sneezing\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Spinal artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Spinal artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Splenic artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Splenic embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Splenic thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Splenic vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Spondylitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Spondyloarthropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Spontaneous heparin-induced thrombocytopenia syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Status epilepticus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stevens-Johnson syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stiff leg syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stiff person syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stillbirth\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Still's disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stoma site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stoma site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stress cardiomyopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Stridor\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Subacute cutaneous lupus erythematosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Subacute endocarditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Subacute inflammatory demyelinating polyneuropathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Subclavian artery embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Subclavian artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Subclavian vein thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sudden unexplained death in epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Superior sagittal sinus thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Susac's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Suspected COVID-19\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Swelling\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Swelling face\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Swelling of eyelid\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Swollen tongue\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Sympathetic ophthalmia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic lupus erythematosus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic lupus erythematosus disease activity index abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic lupus erythematosus disease activity index decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic lupus erythematosus disease activity index increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic lupus erythematosus rash\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic scleroderma\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Systemic sclerosis pulmonary\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tachycardia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tachypnoea\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Takayasu's arteritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Temporal lobe epilepsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Terminal ileitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Testicular autoimmunity\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Throat tightness\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thromboangiitis obliterans\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombocytopenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombocytopenic purpura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombophlebitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombophlebitis migrans\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombophlebitis neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombophlebitis septic\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombophlebitis superficial\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thromboplastin antibody positive\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombosis corpora cavernosa\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombosis in device\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombosis mesenteric vessel\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombotic cerebral infarction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombotic microangiopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombotic stroke\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thrombotic thrombocytopenic purpura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thyroid disorder\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thyroid stimulating immunoglobulin increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Thyroiditis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tongue amyloidosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tongue biting\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tongue oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tonic clonic movements\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tonic convulsion\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tonic posturing\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Topectomy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Total bile acids increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Toxic epidermal necrolysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Toxic leukoencephalopathy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Toxic oil syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tracheal obstruction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tracheal oedema\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tracheobronchitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tracheobronchitis mycoplasmal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tracheobronchitis viral\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Transaminases abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Transaminases increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Transfusion-related alloimmune neutropenia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Transient epileptic amnesia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Transverse sinus thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Trigeminal nerve paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Trigeminal neuralgia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Trigeminal palsy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Truncus coeliacus thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tuberous sclerosis complex\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tubulointerstitial nephritis and uveitis syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tumefactive multiple sclerosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tumour embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Tumour thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Type 1 diabetes mellitus\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Type I hypersensitivity\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Type III immune complex mediated reaction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Uhthoff's phenomenon\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ulcerative keratitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Ultrasound liver abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Umbilical cord thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Uncinate fits\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Undifferentiated connective tissue disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Upper airway obstruction\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Urine bilirubin increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Urobilinogen urine decreased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Urobilinogen urine increased\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Urticaria\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Urticaria papular\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Urticarial vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Uterine rupture\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Uveitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vaccination site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vaccination site vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vagus nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella keratitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella post vaccine\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella zoster gastritis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella zoster oesophagitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella zoster pneumonia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella zoster sepsis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Varicella zoster virus infection\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vasa praevia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vascular graft thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vascular pseudoaneurysm thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vascular purpura\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vascular stent thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vasculitic rash\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vasculitic ulcer\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vasculitis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vasculitis gastrointestinal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vasculitis necrotising\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vena cava embolism\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vena cava thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Venous intravasation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Venous recanalisation\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Venous thrombosis in pregnancy\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Venous thrombosis limb\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Venous thrombosis neonatal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vertebral artery thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vessel puncture site thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Visceral venous thrombosis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"VIth nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"VIth nerve paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vitiligo\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vocal cord paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vocal cord paresis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Vogt-Koyanagi-Harada disease\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Warm type haemolytic anaemia\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Wheezing\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"White nipple sign\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"XIth nerve paralysis\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"X-ray hepatobiliary abnormal\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Young's syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Zika virus associated Guillain Barre syndrome\",\"Source Title\":\"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report\",\"Source Author\":\"Worldwide Safety Pfizer\",\"Source Date\":\"2021-04-30\",\"Source Additional Information\":\"Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization\",\"Source URL\":\"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\"},{\"Possible Vaccine Adverse Events\":\"Adenopathy\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Anaphylaxis\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Arthralgia\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Cardiac collapse\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Coma\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Death\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Multiple neuritis\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Myelitis\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Paralysis of the serratus magnus and other muscles\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Urticaria\",\"Source Title\":\"Neuritis and Multiple Neuritis Following Serum Therapy\",\"Source Author\":\"George Wilson, M.D. and Samuel B. Hadden, M.D.\",\"Source Date\":\"1932-01-09\",\"Source Additional Information\":\"'JAMA's. 1932; 98(2), pages 123-125\",\"Source URL\":\"https://jamanetwork.com/journals/jama/article-abstract/1153665\"},{\"Possible Vaccine Adverse Events\":\"Acute disseminated encephalomyelitis\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Acute myocardial infarction\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Anaphylaxis\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Arthritis and arthralgia/joint pain\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Autoimmune disease\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Convulsions/seizures\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Deaths\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Disseminated intravascular coagulation\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encepholapathy\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Guillain-Barré syndrome\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Kawasaki disease\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Multisystem Inflammatory Syndrome in Children\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Myocarditis/pericarditis\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Narcolepsy and cataplexy\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Non-anaphylactic allergic reactions\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Other acute demyelinating diseases\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Pregnancy and birth outcomes\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Stroke\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Thrombocytopenia\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Transverse myelitis\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Vaccine enhanced disease\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"},{\"Possible Vaccine Adverse Events\":\"Venous thromboembolism\",\"Source Title\":\"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation\",\"Source Author\":\"Steve Anderson, PhD, MPP\",\"Source Date\":\"2020-10-22\",\"Source Additional Information\":\"page 17; Document was Recovered with the Internet Archive: Wayback Machine\",\"Source URL\":\"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download\"}]"]
